MetLife Investment Management, LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1529735
Whippany, NJ
Position in HALO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$24,231,790
-$2,804,706 QoQ
Shares Held
374,931
-6.7% QoQ
Ownership
0.316%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,315,342 across 207 Biotechnology names. HALO ranks #4 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
This page
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
708,527 | $13,858,788 |
All Filings in HALO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,231,790 | 374,931 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $27,036,496 | 401,731 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $25,058,004 | 341,669 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $20,751,922 | 398,922 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $21,934,113 | 343,741 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,945,119 | 145,265 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $7,711,773 | 134,727 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $7,164,157 | 136,825 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,572,509 | 136,984 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,178,724 | 140,117 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,393,381 | 141,188 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $5,294,751 | 146,791 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $5,723,611 | 149,872 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,654,319 | 152,097 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $6,238,897 | 157,787 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $6,919,880 | 157,270 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $6,477,070 | 162,414 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $4,662,590 | 115,956 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $4,823,061 | 118,561 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $5,315,694 | 117,060 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $4,830,411 | 115,865 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $5,239,150 | 122,668 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $1,574,408 | 59,909 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $1,606,160 | 59,909 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $1,030,773 | 57,297 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||